BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33988718)

  • 1. HG-9-91-01 Attenuates Murine Experimental Colitis by Promoting Interleukin-10 Production in Colonic Macrophages Through the SIK/CRTC3 Pathway.
    Fu Y; Ma G; Zhang Y; Wang W; Shi T; Zhu J; Zhang J; Huang Z; Chen J
    Inflamm Bowel Dis; 2021 Oct; 27(11):1821-1831. PubMed ID: 33988718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages.
    Clark K; MacKenzie KF; Petkevicius K; Kristariyanto Y; Zhang J; Choi HG; Peggie M; Plater L; Pedrioli PG; McIver E; Gray NS; Arthur JS; Cohen P
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):16986-91. PubMed ID: 23033494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cells.
    Sundberg TB; Choi HG; Song JH; Russell CN; Hussain MM; Graham DB; Khor B; Gagnon J; O'Connell DJ; Narayan K; Dančík V; Perez JR; Reinecker HC; Gray NS; Schreiber SL; Xavier RJ; Shamji AF
    Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12468-73. PubMed ID: 25114223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.
    Ichikawa N; Yamashita K; Funakoshi T; Ichihara S; Fukai M; Ogura M; Kobayashi N; Zaitsu M; Yoshida T; Shibasaki S; Koshizuka Y; Tsunetoshi Y; Sato M; Einama T; Ozaki M; Umezawa K; Suzuki T; Todo S
    Inflamm Res; 2016 Mar; 65(3):245-60. PubMed ID: 26683259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of the salt
    Wang X; Wang S; Cui Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1793-1803. PubMed ID: 38448372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitis.
    Yoshino T; Nakase H; Honzawa Y; Matsumura K; Yamamoto S; Takeda Y; Ueno S; Uza N; Masuda S; Inui K; Chiba T
    Inflamm Bowel Dis; 2010 Dec; 16(12):2022-33. PubMed ID: 20848491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of SIK2 and SIK3 during differentiation enhances the anti-inflammatory phenotype of macrophages.
    Darling NJ; Toth R; Arthur JS; Clark K
    Biochem J; 2017 Feb; 474(4):521-537. PubMed ID: 27920213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of experimental mouse models of inflammatory bowel disease.
    Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
    Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
    Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
    J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages.
    Hamers AA; van Dam L; Teixeira Duarte JM; Vos M; Marinković G; van Tiel CM; Meijer SL; van Stalborch AM; Huveneers S; Te Velde AA; de Jonge WJ; de Vries CJ
    PLoS One; 2015; 10(8):e0133598. PubMed ID: 26241646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of pyrimidine-5-carboxamide derivatives as novel salt-inducible kinases (SIKs) inhibitors for inflammatory bowel disease (IBD) treatment.
    Cai X; Wang L; Yi Y; Deng D; Shi M; Tang M; Li N; Wei H; Zhang R; Su K; Ye H; Chen L
    Eur J Med Chem; 2023 Aug; 256():115469. PubMed ID: 37178481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
    Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
    Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease.
    Fitzpatrick LR; Deml L; Hofmann C; Small JS; Groeppel M; Hamm S; Lemstra S; Leban J; Ammendola A
    Inflamm Bowel Dis; 2010 Oct; 16(10):1763-77. PubMed ID: 20310011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined administration of SHP2 inhibitor SHP099 and the α7nAChR agonist PNU282987 protect mice against DSS‑induced colitis.
    Xiao J; Zhang G; Gao S; Shen J; Feng H; He Z; Xu C
    Mol Med Rep; 2020 Sep; 22(3):2235-2244. PubMed ID: 32705242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indigo Naturalis ameliorates murine dextran sodium sulfate-induced colitis via aryl hydrocarbon receptor activation.
    Kawai S; Iijima H; Shinzaki S; Hiyama S; Yamaguchi T; Araki M; Iwatani S; Shiraishi E; Mukai A; Inoue T; Hayashi Y; Tsujii M; Motooka D; Nakamura S; Iida T; Takehara T
    J Gastroenterol; 2017 Aug; 52(8):904-919. PubMed ID: 27900483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype.
    Lombardi MS; Gilliéron C; Dietrich D; Gabay C
    J Leukoc Biol; 2016 May; 99(5):711-21. PubMed ID: 26590148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
    Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
    Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus-mediated colonic secretory expression of HMGB1 A box attenuates experimental colitis in mice.
    Zheng X; Lv Y; Li S; Zhang Q; Zhang X; Hao Z
    J Gene Med; 2016 Oct; 18(10):261-272. PubMed ID: 27572454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice.
    Chun J; Lee C; Hwang SW; Im JP; Kim JS
    Life Sci; 2014 Aug; 110(1):23-34. PubMed ID: 24992474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The signaling axis of microRNA-31/interleukin-25 regulates Th1/Th17-mediated inflammation response in colitis.
    Shi T; Xie Y; Fu Y; Zhou Q; Ma Z; Ma J; Huang Z; Zhang J; Chen J
    Mucosal Immunol; 2017 Jul; 10(4):983-995. PubMed ID: 27901018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.